​Applications in medical journals (28 items)

​

​

Hall J and O'Quigley J. (1979)
Reliability of anthropometric measurements.
Aust. J. Nut. 18, 27-33.

​

Hall J., O'Quigley J., et al (1980)
Upper limb anthropometry : the value of measurement variance studies.
Am. J. Clin. Nut. 33, 1846-1851.

​

O'Quigley J. et al (1981)
Prognostic significance of serum proteins in invasive bladder cancer : a
Preliminary report of the E.O.R.T.C. Urological Group.  Eur. J. Cancer 17, 251-255.

​

Hall J.C., O'Quigley J. et al (1981)
Serum levels of albumin, prealbumin and transferrin in patients with large bowel
cancer.  Aust N Z J Surg  51, 387.

​

Hall J.C., O'Quigley J. and Giles G.R. (1981)
Nutritional markers in advanced large bowel cancer.
Marker Proteins in Inflammation . Walter de Gruyter ,New York

​

Rashid S.A.,  O’Quigley J. , Axon, A. T. and Cooper, E.H.  (1982)
Plasma protein profiles and prognosis in gastric cancer.
Brit. J. Cancer 45, 3, 390-394.

​

O'Quigley J. and Cooper E.H. (1982) A simple Markov model relating disease progression to marker levels in gastric cancer. Comm. in Cancer Biology 39, 287-296.

​

Cooper E.H. and O'Quigley J. (1982) Biochemical Markers.
Recent Results in Cancer Research 83,  67-76.

​

Child A., Crawford S.M., Norfolk D.R., O'Quigley J. et al (1983) Evaluation of serum beta-2 microglobulin as a prognostic indicator in myelomatosis.  Brit. J. Cancer 47, 111-115.

​

Schwartz D., Heuchel V., Mayaux M.J. and O'Quigley J. (1983)
Evaluation of early embryonic mortality in donor insemination by a mathematical
model; globally and depending on semen quality.  Gamete Research 8, 371-377.

​

Martin P , Hansen J.,.., O'Quigley J. et al (more than 10 authors) (1988)
Graft failure in patients receiving T-cell depleted HLA identical allogeneic marrow transplants.  

Bone Marrow Transplantation 3, 445-456

​

Anasetti C., Amos D., Beatty M.D,..,O'Quigley J. et al (1989)
Risk factors for graft rejection of marrow transplants from HLA matched donors.
New England Journal of Medicine  320, 197-204.

​

Durnam, D., Anders, K, Fisher, L., O'Quigley J., Bryant, E. and Thomas, E.D. (1989)
Analysis of the origin of marrow cells in bone marrow transplant recipients
using a Y chromosome specific in situ hybridization assay. Blood  74, 2220-2226.

​

Zager R., O'Quigley J. et al (1989)
Acute renal failure following bone marrow transplantation ; a retrospective analysis of 272 patients.   Am. J. Kidney Disease  3, 210-216.

​

Zager R. and O'Quigley J. (1989) Studies of mechanics and protective manoeuvre in myloglobinuric acute renal injury.   Laboratory Investigation  60, 619-629.
   
Schubert, M.A. ,...., O'Quigley J. et al (11 authors) (1990)  Gynecological abnormalities following allogeneic bone marrow transplantation.  Bone Marrow Trans. 5 425-430.

​

O'Quigley J. (1990) Sequential design and analysis of dose finding studies in patients with life threatening disease. Clinical Pharmacol 4, Suppl 2, 81-91.

​

Rosetta L. and O'Quigley J. (1990) Mortality among Serere children in Senegal.
American J. Hum. Biol. Vol. 2 No. 6, 719-726.

​

Christen R.,...,O'Quigley J. and Howell S. (13 authors in total) (1993) Phase 1 pharmacokinetic study of high-dose progesterone and doxorubicin.
J. Clinical Oncology, 11,  2417-2426.

​

O'Quigley J. (1997)
Méthodes statistiques pour la recherche de la dose optimale.
Cahiers de l'Association des Médecins de l'Industrie Pharmaceutique  3, 51-58.
 
Plaxe S., Christen R. O'Quigley J., ... , and Howell S. (1998) Phase I and pharmacokinetic study of intraperitoneal topotecan.  Invest. New Drugs 16 (2), 147-153.
 
Siu, L., Paoletti, X., O'Quigley J., Rowinsky, E., Clark, G., Von Hoff, D. and Eckhardt, G. (1998) Strategies for improvement in dose escalation using the continual
reassessment method in Phase I clinical trials. Annals of Oncology 9, 6050.

​

Holman, P., Bashey, A., Corringham, S.,, Carrier, E., O'Quigley J. and Ball, E. (1999) High dose topotecan plus melphalan: A safe and tolerable preparative regimen for autologous transplantation in multiple myeloma. Blood   94, 2575.

​

Khanna, S., Davis, D., Peterson, B., Tung, H., O'Quigley J. and Deutsch, R. (2000)
Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury.  Critical Care Medicine 28, 1144-51.

​

Holman, P., Joyce, R., Oblon, D., Bashey, A., Carrier, E., Chen, J., Vemuri, L., Corringham, S., O'Quigley J., Ball, E. (2001) A phase I/II study of high dose topotecan (T) with melphalan (M) followed by autologous stem cell transplantation (ASCT) in multiple myeloma and non-Hodgkins lymphoma.   Blood 98, 8-23.

​

Vassal, G., Doz, F., Frappaz, D., Imadalou, K., Sicard, E., Santos, A., O'Quigley J., Germa, C. and Pein, F. (2003) A Phase I study of irinotecan as a 3-week schedule in children with
refractory or recurrent solid tumors.  J. Clin. Oncol. 21, 3844-52.

​

Birgit Geoerger, Gilles Vassal, Francois Doz, O'Quigley J, Muriel Wartelle, Amanda J. Watson, Marie-Anne Raquin, Didier Frappaz, Pascal Chastagner, Jean-Claude Gentet, Herve Rubie, Dominique Couanet, Anne Geoffray, Kamel Djazouli or Latifa Djafari, Geoffrey P. Margison, Francois Pein (2005) Dose-Finding and O6-Alkyguanine-DNA Alkyltransferase Study of Cisplatin Combined with Temozolomide in Pediatric Solid Malignancies.
Brit. J. Cancer  5;93 (5), 529-37

​

Rahn, D., Ray, D., Schlesinger D., Steiner, L., Sheehan, J., O'Quigley J. and Rich, T. (2010)
Gamma Knife radiosurgery for brain metastasis of non-small-cell lung cancer: Is there a difference in outcome between  morning and afternoon treatment?  Cancer 117, 414-20

 

​​